Transcriptional activation of estrogen receptor ERα and ERβ by polycyclic musks is cell type dependent

Toxicology and Applied Pharmacology

Volumn 183, Issue 1, 2002, Pages 1-9

  Schreurs, Richard H M M ^a   Quaedackers, Monique E ^b   Seinen, Willem ^a   Van Der Burg, Bart ^b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b HUBRECHT INSTITUTE   (Netherlands)

Author keywords

(anti)estrogenicity; 4 hydroxytamoxifen; AHTN; Estrogen receptor and ; HHCB; Polycyclic musks

Indexed keywords

1,2,4,6,7,8 HEXAHYDRO 4,6,6,7,8,8 HEXAMETHYLCYCLOPENTA GAMMA 2 BENZOPYRAN; 4 HYDROXYTAMOXIFEN; 6 ACETYTL 1,1,2,4,4,7 HEXAMETHYLTETRALINE; ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MUSK; MUTANT PROTEIN; SELECTIVE ESTROGEN RECEPTOR MODULATOR; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CELL LINE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENCY; DRUG TARGETING; HORMONAL REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; REPORTER GENE; TRANSACTIVATION; TRANSCRIPTION REGULATION;

EID: 0036385849     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.2002.9458     Document Type: Article

References (48)

1. Anstead, G. M., Carlson, K. E., and Katzenellenbogen, J. A. (1997). The estradiol pharmacophore: Ligand structure-estrogen receptor binding affin-ity relationships and a model for the receptor binding site. Steroids 62, 268-303.
2. Arnold, S. F., Robinson, M. K., Notides, A. C., Guillette, L. J., Jr, and McLachlan, J. A. (1996). A yeast estrogen screen for examining the relative exposure of cells to natural and xenoestrogens. Environ. Health Perspect.104(5), 544-548
3. Balk, F., and Ford, R. A. (1999). Environmental risk assessment for the polycyclic musks AHTN and HHCB in the EU. I. Fate and exposure assessment. Toxicol. Lett. 111(1-2), 57-79.
4. Berry, M., Metzger, D., and Chambon, P. (1990). Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen. EMBO J. 9(9), 2811-2818.
5. Berthois, Y., Katzenellenbogen, J. A., and Katzenellenbogen, B. S. (1986). Phenol red in tissue culture media is a weak estrogen: Implications concerning the study of estrogen-responsive cells in culture. Proc. Natl. Acad. Sci. USA 83(8), 2496-2500.
6. Bester, K., Hühnerfuss, H., Lange, W., Rimkus, G. G., and Theobald, N. (1998). Results of non target screening of lipophilic organic pollutants in the German bight II: Polycyclic musk fragrances. Water Res. 32(6), 1857-1863.
7. Brzozowski, A. M., Pike, A. C., Dauter, Z., Hubbard, R. E., Bonn, T., Engstrom, O., Ohman, L., Greene, G. L., Gustafsson, J. A., and Carlquist, M. (1997). Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389(6652), 753-758.
8. Carson-Jurica, M. A., Schrader, W. T., and O'Malley, B. W. (1990). Steroid receptor family: Structure and functions. Endocr. Rev. 11(2), 201-220.
9. Cree, I. A., and Andreotti, P. E. (1997). Measurement of cytotoxicity by ATP-based luminescence assay in primary cell cultures and cell lines. Toxicol. In Vitro 11, 553-556.
10. Danielian, P. S., White, R., Lees, J. A., and Parker, M. G. (1992). Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J. 11(3), 1025-1033.
11. Draisci, R., Marchiafava, C., Ferretti, E., Palleschi, L., Catellani, G., and Anastasio, A. (1998). Evaluation of musk contamination of freshwater fish in Italy by accelerated solvent extraction and gas chromatography with mass spectrometric detection. J. Chromatogr. A 814(1-2), 187-197.
12. Ekena, K., Weis, K. E., Katzenellenbogen, J. A., and Katzenellenbogen, B. S. (1996). Identification of amino acids in the hormone binding domain of the human estrogen receptor important in estrogen binding. J. Biol. Chem. 271(33), 20053-20059.
13. Ekena, K., Katzenellenbogen, J. A., and Katzenellenbogen, B. S. (1998). Determinants of ligand specificity of estrogen receptor-alpha: Estrogen versus androgen discrimination. J. Biol. Chem. 273(2), 693-699.
14. Fromme, H., Otto, T., and Pilz, K. (2001). Polycyclic musk fragrances in different environmental compartments in Berlin (Germany). Water Res. 35(1), 121-128.
15. Gatermann, R., Hellou, J., Hühnerfuss, H., Rimkus, G., and Zitko, V. (1999). Polycyclic and nitro musks in the environment: A comparison between Canadian and European aquatic biota. Chemosphere 38(14), 3431-3441.
16. Gustafsson, J. A. (1998). Raloxifene: Magic bullet for heart and bone? Nat. Med. 4(2), 152-153.
17. Hall, J. M., and McDonnell, D. P. (1999). The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology 140(12), 5566-5578.
18. Jones, P. S., Parrott, E., and White, I. N. (1999). Activation of transcription by estrogen receptor alpha and beta is cell type- and promoter-dependent. J. Biol. Chem. 274(45), 32008-320014.
19. Jordan, V. C. (1998). Antiestrogenic action of raloxifene and tamoxifen: Today and tomorrow. J. Natl. Cancer Inst. 90(13), 967-971.
20. Katzenellenbogen, B. S., Montano, M. M., Le Goff, P., Schodin, D. J., Kraus, W. L., Bhardwaj, B., and Fujimoto, N. (1995). Antiestrogens: Mechanisms and actions in target cells. J. Steroid Biochem. Mol. Biol. 53, 387-393.
21. Korach, K. S., Metzler, M., and McLachlan, J. A. (1978). Estrogenic activity in vivo and in vitro of some diethylstilbestrol metabolites and analogs. Proc. Natl. Acad. Sci. USA 75(1), 468-471.
22. Kuiper, G. G., Enmark, E., Pelto-Huikko, M., Nilsson, S., and Gustafsson, J. A. (1996). Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. USA 93(12), 5925-5930.
23. Kuiper, G. G., Carlsson, B., Grandien, K., Enmark, E., Haggblad, J., Nilsson, S., and Gustafsson, J. A. (1997). Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138(3), 863-870.
24. Kumar, V., Green, S., Stack, G., Berry, M., Jin, J. R., and Chambon, P. (1987). Functional domains of the human estrogen receptor. Cell 51(6), 941-951.
25. Legler, J., van den Brink, C. E., Brouwer, A., Murk, A. J., van der Saag, P. T., Vethaak, A. D., and van der Burg, B. (1999). Development of a stably transfected estrogen receptor-mediated luciferase reporter gene assay in the human T47D breast cancer cell line. Toxicol. Sci. 48(1), 55-66.
26. Lemmen, J. G., Van Den Brink, C. E., Legler, J., Van Der Saag, P. T., and Van Der Burg, B. (2002). Detection of oestrogenic activity of steroids present during mammalian gestation using ER-alpha and ER-beta specific in vitro assays. J. Endocrinol.
27. MacGregor, J. I., and Jordan, V. C. (1998). Basic guide to the mechanisms of antiestrogen action. Pharmacol. Rev. 50(2), 151-196.
28. Mahfoudi, A., Roulet, E., Dauvois, S., Parker, M. G., and Wahli, W. (1995). Specific mutations in the estrogen receptor change the properties of anties-trogens to full agonists. Proc. Natl. Acad. Sci. USA 92(10), 4206-4210.
29. McDonnell, D. P., Clemm, D. L., Hermann, T., Goldman, M. E., and Pike, J. W. (1995). Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens. Mol. Endocrinol. 9(6), 659-669.
30. McInerney, E. M., and Katzenellenbogen, B. S. (1996). Different regions in activation function-1 of the human estrogen receptor required for antiestrogen- and estradiol-dependent transcription activation. J. Biol. Chem. 271(39), 24172-24178.
31. McInerney, E. M., Weis, K. W., Sun, J., Mosselman, S., and Katzenellenbogen, B. S. (1998). Transcription activation by the human estrogen receptor subtype beta (ER beta) studied with ER beta and ER alpha receptor chimeras. Endocrinology 139(11), 4513-4522.
32. Montano, M. M., Muller, V., Trobaugh, A., and Katzenellenbogen, B. S. (1995). The carboxy-terminal F domain of the human estrogen receptor: Role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists. Mol. Endocrinol. 9(7), 814-825.
33. Muller, S., Schmid, P., and Schlatter, C. (1996). Occurrence of nitro and non-nitro benzenoid musk compounds in human adipose tissue. Chemosphere 33(1), 17-28.
34. Paech, K., Webb, P., Kuiper, G. G., Nilsson, S., Gustafsson, J., Kushner, P. J., and Scanlan, T. S. (1997). Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science 277(5331), 1508-1510.
35. Pfahl, M., Tzukerman, M., Zhang, X., Lehmann, J. M., Hermann, T., Wills, K. N., and Graupner, G. (1990). Nuclear retinoic acid receptors: Cloning, analysis, and function. Methods Enzymol. 189, 256-270.
36. Pons, M., Gagne, D., Nicolas, J. C., and Mehtali, M. (1990). A new cellular model of response to estrogens: A bioluminescent test to characterize (anti)estrogen molecules. BioTechniques 9, 450-459.
37. Quaedackers, M. E., Van Den Brink, C. E., Wissink, S., Schreurs, R. H., Gustafsson, J. A., Van Der Saag, P. T., and Van Der Burg, B. B. (2001). 4-Hydroxytamoxifen trans-represses nuclear factor-kappa B activity in human osteoblastic U2-OS cells through estrogen receptor (ER)alpha, and not through ER beta. Endocrinology 142(3), 1156-1166.
38. Rimkus, G. G. (1999). Polycyclic musk fragrances in the aquatic environment. Toxicol. Lett. 111(1-2), 37-56.
39. Rimkus, G. G., and Wolf, M. (1996). Polycyclic musk fragrances in human adipose tissue and human milk. Chemosphere 33(10), 2033-2043.
40. Routledge, E. J., and Sumpter, J. P. (1996). Estrogenic activity of surfactants and some of their degradation products assessed using a recombinant yeast screen. Environ. Tox, Chem. 15, 241-248.
41. Sambrook, J., et al. (1989). Molecular Cloning: A Laboratory Manual, pp. 1630-1636. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
42. Seinen, W., Lemmen, J. G., Pieters, R. H., Verbruggen, E. M., and van der Burg, B. (1999). AHTN and HHCB show weak estrogenic - but no uterotrophic activity. Toxicol. Lett. 111(1-2), 161-168.
43. Soto, A. M., Lin, T., Justicia, H., Silvia, R. M., and Sonnenschein, C. (1992). An "in culture" bioassay to assess the estrogenicity of xenobiotics (E-SCREEN). In: Chemically Induced Alterations in Sexual Development: The Wildlife/Human Connection (Colborn, T., and Clement, C. R., Eds.), pp. 295-309. Princeton Sci. Pub., Princeton, NJ.
44. Tsai, M. J., and O'Malley, B. W. (1994). Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63, 451-486.
45. Tzukerman, M. T., Esty, A., Santiso-Mere, D., Danielian, P., Parker, M. G., Stein, R. B., Pike, J. W., and McDonnell, D. P. (1994). Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol. Endocrinol. 8(1), 21-30.
46. Van De Plassche, E. J. and Balk, F. (1997). Environmental Risk Assessment of the Polycyclic Musks AHTN and HHCB According to the EU-TGD. RIVM Report No. 601503008.
47. Verbruggen, E. M. J., Van Loon, W. M. G. M., Tonkes, M., Van Duijn, P., Seinen, W., and Hermens, J. L. M. (1999). Biomimetic extraction as a tool to identify chemicals with high bioconcentration potential: An illustration by two fragrances in sewage treatment plant effluents and surface waters. Environ. Sci. Technol. 33, 801-806.
48. Zacharewski, T. R. (1997). In vitro bioassays for assessing estrogenic substances. Environ. Sci. Technol. 31, 613-623